| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/13/2008 | WO2008009804A3 Multilayer tablet having a disintegration layer |
| 03/13/2008 | WO2008007383A8 Dried electrified hydrocolloid gels having unique structure and porosity |
| 03/13/2008 | WO2008006716A3 Improvements relating to pharmaceutical compositions |
| 03/13/2008 | WO2008003321A3 Compositions with several hyaluronic acid fractions for cosmetic use |
| 03/13/2008 | WO2008000453A3 Process for preparing a solid dosage form |
| 03/13/2008 | WO2007150063A3 Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements |
| 03/13/2008 | WO2007148116A3 Topical pharmaceutical formulations |
| 03/13/2008 | WO2007147902A3 Rehydratable pharmaceutical product |
| 03/13/2008 | WO2007144323A3 Solid forms containing meloxicam with improved taste and process for their preparation |
| 03/13/2008 | WO2007144139A3 Pharmaceutical compositions with biological barriers permeation enhancing properties |
| 03/13/2008 | WO2007143381A3 Microparticles and methods for production thereof |
| 03/13/2008 | WO2007139886A3 Duloxetine hydrochloride delayed release formulations |
| 03/13/2008 | WO2007133711B1 Pharmaceutical compositions for vein irritating drugs |
| 03/13/2008 | WO2007129329A3 Extended release pharmaceutical formulation comprising venlafaxine hydrochloride |
| 03/13/2008 | WO2007123872A3 Polyesteramide platform for site specific drug delivery |
| 03/13/2008 | WO2007117435A3 Coatings formed from stimulus-sensitive material |
| 03/13/2008 | WO2007112267A3 Powder filling processes |
| 03/13/2008 | WO2007100699A3 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| 03/13/2008 | WO2007099396A3 Antibiotic kit and composition and uses thereof |
| 03/13/2008 | WO2007093796A3 Tobacco extraction methods and formulations |
| 03/13/2008 | WO2007089544A3 Biodegradable non-ophthalmic implants and related methods |
| 03/13/2008 | WO2007085024A3 Dosage form and method for the delivery of drugs of abuse |
| 03/13/2008 | WO2007084617A3 Film bandage for mucosal administration of actives |
| 03/13/2008 | WO2007079391A3 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 03/13/2008 | WO2007077581B1 Pharmaceutical compositions |
| 03/13/2008 | WO2007052299A3 Controlled release formulation |
| 03/13/2008 | WO2007052167A3 Stable composition for a pharmaceutical formulation containing olanzapine |
| 03/13/2008 | WO2007042281A3 Processing of chitosan and chitosan derivatives |
| 03/13/2008 | WO2007041053A3 Formulation comprising metformin and vildagli ptin |
| 03/13/2008 | WO2001032068A3 Time-released substance delivery device |
| 03/13/2008 | WO2001028491A3 Method and composition for the treatment of dermatologic diseases |
| 03/13/2008 | US20080065236 Implantable Medical Device Management System |
| 03/13/2008 | US20080065050 Device and method for detecting and treating chemical and biological agents |
| 03/13/2008 | US20080064854 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/13/2008 | US20080064789 Microencapsulated particles and process for manufacturing same |
| 03/13/2008 | US20080064759 Process for preparing fenofibrate compositions |
| 03/13/2008 | US20080064713 Dry Syrup Containing Loratadine |
| 03/13/2008 | US20080064711 Composition for treating oral cavity and Mucousal infections |
| 03/13/2008 | US20080064674 Pharmaceutical Compositions |
| 03/13/2008 | US20080064672 Compositions containing topical active agents and pentyleneglycol |
| 03/13/2008 | US20080064640 Particularly drugs and cosmetic agents; ethoxylated meadowform oil having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 03/13/2008 | US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080063898 Materials containing multiple layers of vesicles |
| 03/13/2008 | US20080063727 Human growth hormone, bovine, somatotropin, growth hormone releasing hormone, peptide; injection formulation dispersed in medium of buffered aqueous solution, ethanol, propyleneglycol, polyethyleneglycol, vegetable oil, mineral oil; aerosol formulation water-soluble hyaluronic acid, inorganic salt |
| 03/13/2008 | US20080063726 Micronized fenofibrate; polyvinylpyrrolidone, polyvinyl alcohol, hydroxypropylcellulose hydrophilic polymer; sodium lauryl sulfate, monooleate, monolaurate, monopalmitate surfactant; starch, colloidal silica, cross-linked polyvinyl pyrrolidone inert hydrosoluble carrier particles; hypolipemiant |
| 03/13/2008 | US20080063725 Reservoir type, modified release of active principle; crush resistant; resists immediate dose dumping in ethanol; prevents abuse, misuse, drug addiction related behavior with stupefacients, analgesics or narcotics; microparticles coated with water-insoluble cellulose derivatives, nitrogenous copolymers |
| 03/13/2008 | US20080063724 Methods and compostions for treating proliferative diseases |
| 03/13/2008 | US20080063722 Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
| 03/13/2008 | US20080063721 Sustained release microparticle; a biodegradable and biocompatible polymer; active agent risperidone, 9-hydroxy-risperidone; pharmaceutically acceptable acid addition salts; inhibiting serotonergic or dopaminergic overstimulation |
| 03/13/2008 | US20080063720 Delivery System |
| 03/13/2008 | US20080063719 Pharmaceutical Compositions |
| 03/13/2008 | US20080063718 Delivery Systems For Delivering Functional Compounds to Substrates and Processes of Using the Same |
| 03/13/2008 | US20080063717 Anti-NCR antibody or immunoreactive fragments and an interleukin, cytokine; administered together or separately; tablet, powder, pastes, patches, granules, microgranules, nanoparticules, colloid solution, aqueous solution, injectable solutions, sprays, or liposomes; subcutaneous injection |
| 03/13/2008 | US20080063716 Polymerizing alkenoate monomers, ethylene glycol diacrylate cross-linking agent; form a suspension of hydrogel particles; delivering a biologically active agent in vivo; biomedical applications, joint reconstruction, wound repair, drug delivery, cosmetic surgery |
| 03/13/2008 | US20080063715 Extracellular matrix to treat malignancy in mammals |
| 03/13/2008 | US20080063714 Triazene derivatives non-covalently crosslinked are non-polymeric, carboxy functional groups, partial aromatic or heteroaromatic character; matrix stable in acidic environment of the stomach; will dissolve in non-acidic environment of intestine; matrix will protect a drug from enzymatic degradation |
| 03/13/2008 | US20080063713 Particulate form of a pharmaceutical composition which is easy to swallow |
| 03/13/2008 | US20080063712 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 03/13/2008 | US20080063711 Controlled Release Nisoldipine Compositions |
| 03/13/2008 | US20080063710 Rapidly Disintegrating Tablet and Production Method Thereof |
| 03/13/2008 | US20080063709 Trisecting, quadrisecting, and a pentasecting score pattern in or on a tablet; psychotherapeutic doxepin hydrochloride; enhanced dosage flexibility |
| 03/13/2008 | US20080063708 Low solubility drug dispesed in concentration enhancing hydroxypropyl methyl cellulose acetate succinate (or phthalate), cellulose acetate phthalate, (or trimellitate), carboxymethyl ethyl cellulose, hydroxypropyl methyl cellulose, poloxamers, polyvinylpyrrolidone,or polyvinyl alcohol; bioavailability |
| 03/13/2008 | US20080063707 Controlled release tablet formulations for the prevention of arrhythmias |
| 03/13/2008 | US20080063706 Methods and Medicaments for Administration of Ibuprofen |
| 03/13/2008 | US20080063705 Solid Pharmaceutical Composition Comprising Donepezil Hydrochloride |
| 03/13/2008 | US20080063704 Storage stability, waterproof; microcrystalline cellulose as diluent; magnesium stearate as lubricant; hard gelatin capsule |
| 03/13/2008 | US20080063703 Ingestible capsule has stored drug; environmentally-sensitive mechanism, adapted to change a state of responsively to a disposition of capsule within gastrointestinal (GI) tract; controller adapted to facilitate passage through an epithelial layer by driving electrode to apply pulses; enhanced absorption |
| 03/13/2008 | US20080063702 Liposomal Formulations Comprising an Amphipathic Weak Base Like Tempamine for Treatment of Neurodegenerative Conditions |
| 03/13/2008 | US20080063701 Lipids of a liposome comprising cationic N1-cholesteryloxycarbonyl-3,7-diazanononane-1,9-diamine and/or noncationic dioleoyl phosphatidylethanolamine and short interference RNA (siRNA) are coupled, reversibly or irreversibly, to one or more polymers; drug delivery; freeze drying |
| 03/13/2008 | US20080063700 Non-cationic surface carrier that accumulates on damaged tissue from laser, inflammation, ischemia, reperfusion injuries, bacterial toxin, oxidative stress, tumor or thrombus formation, and/or bleeding; functions as a drug for controlling platelet functions; drug delivery |
| 03/13/2008 | US20080063699 Method of Administering Cationic Liposomes Comprising an Active Drug |
| 03/13/2008 | US20080063698 Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
| 03/13/2008 | US20080063696 Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant |
| 03/13/2008 | US20080063695 Medical dressings include hydrophilic, hydrophobic, drug delivery, and release layers; adhesive tapes, absorbents; high moisture vapor transmission rate |
| 03/13/2008 | US20080063691 Fatty Acid Desaturases From Primula |
| 03/13/2008 | US20080063688 Biomedical devices with antimicrobial coatings |
| 03/13/2008 | US20080063687 Injectable sustained release delivery devices |
| 03/13/2008 | US20080063682 treatment of surgical adhesions, keloid; continuously controlled release a therapeutic agent in combination with a fucoidan |
| 03/13/2008 | US20080063675 Aloe Powder, Aloe Juice, and Method for Producing the Same |
| 03/13/2008 | US20080063671 Hemostatic bone graft |
| 03/13/2008 | US20080063670 Nitroimidazole composition and method |
| 03/13/2008 | US20080063669 treating fungal infections with aqueous composition free of crystals of terconazole; inhibiting the crystallization by adding citric acid; improve therapeutic release of terconazole drug |
| 03/13/2008 | US20080063668 Nitroimidazole and terconazole composition and method |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063631 prophylaxis of vascular system disorders in mammals by administering apoptotic cells and/or bodies derived from leukocytes or lymphocytes |
| 03/13/2008 | US20080063626 Minimization of drug oxidation in drug irradiated excipients formulations |
| 03/13/2008 | US20080063609 compact mixture of gum particles, elastomers and emulsifiers, having improved texture and mouth-feel; candy |
| 03/13/2008 | US20080063608 Pharmaceutical Compositions for Inhalation Containing an Anticholinergic, Corticosteroid, and Betamimetic |
| 03/13/2008 | US20080063607 Oleaginous pharmaceutical and cosmetic foam |
| 03/13/2008 | US20080063606 Pulmonary delivery of aminoglycoside |
| 03/13/2008 | US20080063604 Method and composition for the site-selective gene delivery using viruses |
| 03/13/2008 | US20080061961 Methods and Systems for semi-automatic adjustment of medical monitoring and treatment. |
| 03/13/2008 | US20080061459 Process for Producing Microsphere with Use of Metal Substrate having Through-Hole |
| 03/13/2008 | US20080060645 Dry Powder Inhalant Composition |
| 03/13/2008 | US20080060644 Method Of Treating Diabetes Mellitus In A Patient |
| 03/13/2008 | US20080060641 Methods and systems for operating an aerosol generator |
| 03/13/2008 | DE202007016424U1 Minimal Invasive medizinische Implantate zur gesteuerten Medikamentenzuführung Minimally invasive medical implants for controlled drug delivery |
| 03/13/2008 | DE19905801B4 Verfahren zur Herstellung folienförmiger Darreichungsformen Process for producing film-like administration forms |
| 03/13/2008 | DE10224607B4 Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung In film form, disintegratable formulations for drug delivery and methods for their preparation |